(Q35151831)

6 August 2017

1 reference

title

Autologous cancer vaccine: a novel formulation (English)

1 reference

6 August 2017

Tadao Ohno

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Microbiology and Immunology

6 August 2017

published in

1 reference

6 August 2017

volume

47

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

255-263

1 reference

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

The challenge of fetal gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

T cell recognition of human tumors: implications for molecular immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

A molecular model of MHC class-I-restricted antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03393.X

10.1111/J.1348-0421.2003.TB03393.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference